Patents by Inventor Gavin A. Whitlock

Gavin A. Whitlock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors
    Patent number: 10065964
    Abstract: The present invention relates to compounds of formula (Ia), (Ib) or (Ic): to pharmaceutically acceptable salts therefore and to pharmaceutically acceptable solvates of said compounds and salts, wherein the substituents are defined herein; to compositions containing such compounds; and to the uses of such compounds in the treatment of various diseases, particularly asthma, COPD, allergic rhinitis, chronic sinusitis, atopic dermatitis, psoriasis, rosacea, alopecia, allergic conjunctivitis and dry eye disease.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: September 4, 2018
    Assignee: Ziarco Pharma Ltd.
    Inventors: Gavin A. Whitlock, Paul Alan Glossop
  • 2-(2-AMINOCYCLOHEXYL)AMINO-PYRIMIDINE-5-CARBOXAMIDES AS SPLEEN TYROSINE KINASE(SYK) INHIBITORS
    Publication number: 20170145019
    Abstract: The present invention relates to compounds of formula (Ia), (Ib) or (Ic): to pharmaceutically acceptable salts therefore and to pharmaceutically acceptable solvates of said compounds and salts, wherein the substituents are defined herein; to compositions containing such compounds; and to the uses of such compounds in the treatment of various diseases, particularly asthma, COPD, allergic rhinitis, chronic sinusitis, atopic dermatitis, psoriasis, rosacea, alopecia, allergic conjunctivitis and dry eye disease.
    Type: Application
    Filed: December 13, 2016
    Publication date: May 25, 2017
    Inventors: Gavin A. WHITLOCK, Paul Alan GLOSSOP
  • Substituted pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors
    Patent number: 9533989
    Abstract: The present invention relates to compounds of formula (Ia), (Ib) or (Ic): to pharmaceutically acceptable salts therefore and to pharmaceutically acceptable solvates of said compounds and salts, wherein the substituents are defined herein; to compositions containing such compounds; and to the uses of such compounds in the treatment of various diseases, particularly asthma, COPD, allergic rhinitis, chronic sinusitis, atopic dermatitis, psoriasis, rosacea, alopecia, allergic conjunctivitis and dry eye disease.
    Type: Grant
    Filed: September 18, 2013
    Date of Patent: January 3, 2017
    Assignee: Ziarco Pharma Ltd.
    Inventors: Gavin A. Whitlock, Paul Alan Glossop
  • 2-(-Aminocyclohexyl)Amino-Pyrimidine-5-Carboxamides as Spleen Tyrosine Kinasei(SYK) Inhibitors
    Publication number: 20150232470
    Abstract: The present invention relates to compounds of formula (Ia), (Ib) or (Ic): to pharmaceutically acceptable salts therefore fore and to pharmaceutically acceptable solvates of said compounds and salts, wherein the substituents are defined herein; to compositions containing such compounds; and to the uses of such compounds in the treatment of various diseases, particularly asthma, COPD, allergic rhinitis, chronic sinusitis, atopic dermatitis, psoriasis, rosacea, alopecia, allergic conjunctivitis and dry eye disease
    Type: Application
    Filed: September 18, 2013
    Publication date: August 20, 2015
    Inventors: Gavin A. Whitlock, Paul Alan Glossop